Hydrophilic Linkers Reduce Protein Aggregation in Antibody-Drug Conjugates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The use of hydrophobic linkers in drug conjugates often results in protein aggregation, making it difficult to achieve high drug loading while maintaining the affinity of the carrier protein, which is problematic for targeted cancer therapy as it increases the risk of nonspecific toxicity and immunogenicity.
Innovation Solution
The development of hydrophilic linkers containing phosphinate, sulfonyl, and/or sulfoxide groups to link drugs to cell-binding agents, such as antibodies, reducing aggregation and enabling higher drug loading ratios, thereby enhancing potency and overcoming multidrug resistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If hydrophobic linkers are used in drug conjugates, then the conjugation reaction can proceed, but protein aggregation occurs which reduces manufacturing precision and increases immunogenicity
Solution Approach 1:
The patent changes the chemical parameter of the linker from hydrophobic to hydrophilic by incorporating phosphinate, sulfonyl, and/or sulfoxide groups. This parameter change fundamentally alters the linker's interaction with water and protein surfaces, preventing aggregation while maintaining conjugation capability. The hydrophilic character of these groups creates favorable solvation effects that keep the conjugate molecules dispersed in aqueous media.
Solution Approach 2:
The patent creates a composite linker structure combining hydrophilic functional groups (phosphinate, sulfonyl, sulfoxide) with drug-linking capabilities. This composite approach integrates multiple functions: the hydrophilic groups prevent aggregation while the reactive groups enable drug conjugation, achieving both ease of manufacture and high manufacturing precision simultaneously.
2Quantity of substance
If higher drug loading is achieved using hydrophobic linkers, then potency increases, but protein aggregation increases which increases nonsspecific toxicity and immunogenicity
Solution Approach 1:
By changing the linker's hydrophobicity parameter to hydrophilicity through phosphinate, sulfonyl, and/or sulfoxide groups, the patent enables high drug loading without the aggregation that would otherwise occur. The hydrophilic groups provide steric and solvation barriers that prevent protein-protein interactions even at high drug-to-antibody ratios, thereby maintaining safety while achieving high potency.
3Reliability
If hydrophobic linkers are used to maintain carrier protein affinity, then targeted delivery is achieved, but protein aggregation occurs reducing productivity
Solution Approach 1:
The patent changes the linker's solubility parameter from hydrophobic to hydrophilic, which prevents aggregation during the conjugation process and purification steps. This parameter change ensures that high-yield production methods can be used without forming aggregates that would reduce the final product yield and require additional purification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrophilic linkers minimize protein aggregation, allow for higher drug loading, and facilitate the retention of the drug within target cells, effectively combating multidrug-resistant cells by releasing the drug and maintaining the affinity of the carrier protein.
Implementation Method 1
The development of hydrophilic linkers containing phosphinate, sulfonyl, and/or sulfoxide groups to link drugs to cell-binding agents, such as antibodies, reducing aggregation
Implementation Method 2
The hydrophilic linkers minimize protein aggregation, allow for higher drug loading, and facilitate the retention of the drug within target cells, effectively combating multidrug-resistant cells by releasing the drug
Data Source
AI summary
Cell binding agent-drug conjugates comprising hydrophilic linkers, and methods of using such linkers and conjugates are provided.